AZN's Daiichi Sankyo-partnered datopotamab deruxtecan fails to show overall survival benefits in a breast cancer study. Stock ...

If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis ...

Daiichi Sankyo and AstraZeneca saw a dip in stock prices after announcing that their Phase III TROPION-Breast01 trial for ...

This briefing covers notable health news: the US is donating 1 million mpox vaccine doses to Africa, AstraZeneca’s breast ...

PARIS: European shares closed higher on Monday as a soft business activity reading strengthened the case for more monetary ...

IDEAYA Bioscience’s rare cancer drug shows benefit in interim Phase II data, with the company announcing the drugs Phase III ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16,870.25 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

'He is a disgrace': Congress slams TN RN Ravi governor for 'secularism' remark Congress denounced Tamil Nadu Governor RN Ravi's claim that secularism is a European concept as outrageous and ...

The BJP has demanded Karnataka Chief Minister Siddaramaiah resign, shortly after the High Court ruled in favour of Governor Thawar Chand Gehlot's order sanctioning his prosecution in the alleged ...

Sep. 20, 2024 — A research group has developed a new COVID-19 testing system using Janus particles -- microparticles with two sides possessing distinctive molecular properties. These particles ...

#stocks-summary Seoul shares rise for 6th day on U.S. rate cut hopes SEOUL, Sept. 24 (Yonhap) -- Seoul shares closed higher Tuesday to extend their winning streak to a sixth day, driven by hopes for ...